Glenmark Mometasone Cream Recall: Gritty Texture Complaints
Glenmark Pharmaceuticals recalls 0.1% Mometasone Furoate Cream due to gritty texture complaints. This Rx-only cream may cause irritation. Check NDC 68462019255 for affected batches.
Lower-risk recall
CGMP Deviations: Market complaints related to "gritty texture".
Contact the company
What happened, in plain English
Glenmark is recalling 0.1% Mometasone Furoate Cream (45g) because some users reported a gritty texture. This could cause skin irritation, so affected users should stop using it. Read more at govinfonow.com/recall/41044-glenmark-mometasone-cream-recall-gritty-texture-complaints.
Source Summary by GovInfoNow · govinfonow.com/recall/41044-glenmark-mometasone-cream-recall-gritty-texture-complaints · Updated October 7, 2026 · FDA enforcement record: FDA #D-0336-2018
Cite this page
“Glenmark Mometasone Cream Recall: Gritty Texture Complaints.” GovInfoNow, updated October 7, 2026. https://govinfonow.com/recall/41044-glenmark-mometasone-cream-recall-gritty-texture-complaints. Based on FDA recall #D-0336-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0336-2018%22&limit=1).
Why it’s dangerous
The cream has a gritty texture that some users found unpleasant. This could cause skin irritation, but it does not pose a serious injury risk.
Who’s affected
People with a prescription for this cream are affected. Those with sensitive skin may experience irritation from the gritty texture.
How to tell if you have this one
Check for the NDC code 68462019255 on the product label. The batch number is 05170598 and it expires March 2019.
- Brand
Glenmark- Product
Glenmark Mometasone Furoate Cream, USP, 0.1%, 45 g Rx Only Manufactured by: Glenmark Pharmaceuticals Ltd. Village- Category
Drug
What to do — step by step
Check Product Label
Look for the NDC code 68462019255 and batch number 05170598 on the cream container.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Product was distributed throughout the United States.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 10 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Other Glenmark recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0336-2018 (November 20, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0336-2018 to see it in context.
- Plain-language summary written by qwen3:4b on October 7, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.